Centaurus Financial, Inc. Regeneron Pharmaceuticals, Inc. Transaction History
Centaurus Financial, Inc.
- $1.45 Billion
- Q4 2024
A detailed history of Centaurus Financial, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Centaurus Financial, Inc. holds 196 shares of REGN stock, worth $118,301. This represents 0.01% of its overall portfolio holdings.
Number of Shares
196
Previous 120
63.33%
Holding current value
$118,301
Previous $126,000
10.32%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding REGN
# of Institutions
1,475Shares Held
87.4MCall Options Held
1.51MPut Options Held
1.42M-
Vanguard Group Inc Valley Forge, PA9.41MShares$5.68 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.1 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.26 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.92 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$2.86 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $64.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...